RBC Capital Reiterates Outperform Rating on CVS Health (CVS)

RBC Capital analyst Ben Hendrix reiterated an Outperform rating and $93.00 price target on CVS Health (NYSE: CVS).

The analyst commented: "Heading into next week’s Investor Day on Tuesday, we maintain confidence in CVS as the best positioned MCO in our coverage for next year given solid execution through the year in the Health Care Benefits business in a difficult utilization backdrop (especially stabilization in Medicare Advantage margin), Caremark’s leadership in the industry shift to rebatefree PBM models, and growth achieved in the Pharmacy and Consumer Wellness segment. We are reiterating OP and $93 price target."

For an analyst ratings summary and ratings history on CVS Health click here. For more ratings news on CVS Health click here.

Shares of CVS Health closed at $75.00 yesterday.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• Dell Technologies (DELL) added to S&P 100 index
• Grindr settles UK privacy lawsuit for £26 million